Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 27, 2000

View Archived Issues

Potent and selective octapeptide sst3 receptor antagonist identified by Swiss, U.S. researchers

Myogen and BASF to codevelop BSF-208075

Zonagen and Wyeth-Ayerst sign human contraceptive vaccine agreement

Oxford GlycoSciences and Pfizer enter biomarker discovery alliance

AstraZeneca continues to make progress across development portfolio

SLIL designs conformationally restricted polyamine analogues for cancer therapy

AstraZeneca seeks FDA approval for pediatric indication of Naropin

EU recommends approval of PegIntron/Rebetol combination for hepatitis C treatment

CeNeS grants license to Shire for dopamine D1 agonist program

Japanese launch of maxacalcitol announced

Inflazyme's novel asthma therapy enters phase II following U.K. approval

R.W. Johnson delays North American phase III trial of influenza inhibitor

Starlix approved by FDA for treatment of type 2 diabetes

Actis for erectile dysfunction approved by FDA for OTC marketing

Once-daily Detrol approved by FDA for treatment of overactive bladder

Novel method for treating autoimmune diseases revealed by UAB Research Foundation

Sumitomo discloses thiourea derivatives with ECE-inhibitory activity

Sumitomo reports quinazoline derivatives with potential for allergic disease treatment

Novel steroid compounds demonstrate anticancer potential

Tanabe Seiyaku claims isoquinoline derivatives with cardiovascular activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...